Clinical Trial Is First To Use A Human Neural Stem Cell Line To Deliver An Anticancer …
City of Hope researchers received approval from the U.S. Food and Drug Administration (FDA) to conduct the first-in-human study of a neural stem cell-based therapy targeting recurrent high-grade gliomas, the most …
[Read the full article here]Related News:
Clinical Trial Is First To Use A Human Neural Stem Cell Line To Deliver An Anticancer Therapeutic Agent
FDA approves first human neural stem cell clinical trial to treat brain tumors
FDA approves first human neural stem cell clinical …